Key takeaway
In a trial of 205 UK adults with insomnia and depressive symptoms, digital CBT-I did not change recognition accuracy for happy (3.01, P = .15) or sad faces (-0.54, P = .72) at 10 weeks, yet lowered insomnia (-4.27) and depressive symptoms (-3.91) compared with sleep hygiene education. Participants were recruited online and mostly women (80.8%), and the mediation findings are exploratory.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Cognitive behavioral therapy for insomnia (CBT-I) reduces depressive symptoms, but how it does so is unclear. The authors tested whether it reduces the negative bias in reading emotional faces, and whether such changes explain better mood.
Who and how
Randomized clinical trial in UK adults who met criteria for insomnia disorder and had a Patient Health Questionnaire-9 score of 10 or more, recruited online between April 26, 2021, and January 24, 2022. 205 participants were randomly assigned to a 6-session digital CBT-I program (n = 101) or a sleep hygiene webpage (n = 104), and assessed at 5 and 10 weeks. Coprimary outcomes were accuracy for happy and sad facial expressions at 10 weeks; secondary outcomes included insomnia, depressive symptoms, affect, emotional regulation, worry, perseverative thinking, sleep midpoint and social jet lag. Intention-to-treat analysis.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Mean age was 49.3 years (SD 10.1); 165 (80.8%) were women; retention was 85.7% (175 participants).
- 2The coprimary outcomes showed no significant difference at 10 weeks: happy faces 3.01 (97.5% CI -1.67 to 7.69; P = .15; Cohen d = 0.24), sad faces -0.54 (97.5% CI -3.92 to 2.84; P = .72; Cohen d = -0.05).
- 3Compared with sleep hygiene education, CBT-I reduced insomnia severity (adjusted difference -4.27, 95% CI -5.67 to -2.87), depressive symptoms (-3.91, -5.20 to -2.62), negative affect (-2.75), emotional regulation difficulties (-5.96), worry (-8.07) and perseverative thinking (-4.21), and raised positive affect (4.99).
- 4Earlier change at week 5 in negative affect (29.7% mediated), worry (24.4%) and emotion regulation difficulties (21.9%) mediated the effect on depression at 10 weeks. No serious adverse events were reported to the trial team.
Limits & uncertainty
- 1Participants were recruited online and were mostly women, with some loss to follow-up (retention 85.7%), so results may not fit other groups.
- 2The comparison was a sleep hygiene webpage, a weak control, so the gap partly reflects a comparison with minimal intervention, and follow-up ended at 10 weeks.
- 3Mediation analyses of secondary measures cannot establish that changes in worry or affect cause the depression improvement; the face-recognition test may not be sensitive enough to detect effects, as 97.5% CIs are wide. This reading is based on the abstract only.
What to take from it
Digital CBT-I improved sleep and depressive symptoms in people with both problems over 10 weeks, and the benefit seems to run partly through lower worry and negative feelings rather than through changes in how faces are read. For persistent insomnia or low mood, discuss treatment options with a clinician.
Reading your own data
CBT-I outcomes are usually measured with sleep diaries and questionnaires, and a watch's sleep duration and bedtime regularity can complement these. Wearable sleep stages are estimates; focus on consistent sleep and wake times and weekly trends in your own sleep duration.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Importance
Cognitive behavioral therapy for insomnia (CBT-I) has been shown to reduce depressive symptoms, but the underlying mechanisms are not well understood and warrant further examination.
Objective
To investigate whether CBT-I modifies negative bias in the perception of emotional facial expressions and whether such changes mediate improvement in depressive symptoms.
Design, setting, and participants
A randomized clinical trial of digital CBT-I vs sleep hygiene education was conducted. Adults living in the UK who met diagnostic criteria for insomnia disorder and Patient Health Questionnaire-9 criteria (score ≥10) for depression were recruited online from the community and randomly assigned to either a 6-session digital CBT-I program or a sleep hygiene webpage. Participant recruitment took place between April 26, 2021, and January 24, 2022, and outcomes were assessed at 5 and 10 weeks post randomization. Data analysis was performed from December 1, 2022, to March 1, 2023.
Main outcomes and measures
Coprimary outcomes were recognition accuracy (percentage) of happy and sad facial expressions at 10 weeks assessed with the facial expression recognition task. Secondary outcomes were self-reported measures of insomnia, depressive symptoms, affect, emotional regulation difficulties, worry, perseverative thinking, midpoint of sleep, social jet lag, and the categorization of and recognition memory for emotional words. Intention-to-treat analysis was used.
Results
A total of 205 participants were randomly assigned to CBT-I (n = 101) or sleep hygiene education (n = 104). The sample had a mean (SD) age of 49.3 (10.1) years and was predominately female (165 [80.8%]). Retention was 85.7% (n = 175). At 10 weeks, the estimated adjusted mean difference for recognition accuracy was 3.01 (97.5% CI, -1.67 to 7.69; P = .15; Cohen d = 0.24) for happy facial expressions and -0.54 (97.5% CI, -3.92 to 2.84; P = .72; Cohen d = -0.05) for sad facial expressions. At 10 weeks, CBT-I compared with control decreased insomnia severity (adjusted difference, -4.27; 95% CI, -5.67 to -2.87), depressive symptoms (adjusted difference, -3.91; 95% CI, -5.20 to -2.62), negative affect (adjusted difference, -2.75; 95% CI, -4.58 to -0.92), emotional regulation difficulties (adjusted difference, -5.96; 95% CI, -10.61 to -1.31), worry (adjusted difference, -8.07; 95% CI, -11.81 to -4.33), and perseverative thinking (adjusted difference, -4.21; 95% CI, -7.03 to -1.39) and increased positive affect (adjusted difference, 4.99; 95% CI, 3.13-6.85). Improvement in negative affect, emotional regulation difficulties, and worry at week 5 mediated the effect of CBT-I on depression severity at 10 weeks (% mediated: 21.9% Emotion regulation difficulties; 24.4% Worry; and 29.7% Negative affect). No serious adverse events were reported to the trial team.
Conclusions and relevance
This randomized clinical trial did not find evidence that CBT-I engenders change in the perception of facial expressions at post treatment, despite improvements in insomnia and depressive symptoms. Early change in negative affect, emotional regulation difficulties, and worry mediated lagged depression outcomes and deserve further empirical scrutiny.
Trial registration
isrctn.org Identifier: ISRCTN17117237.
Sources & attribution
Emotional Processing Following Digital Cognitive Behavioral Therapy for Insomnia in People With Depressive Symptoms: A Randomized Clinical Trial.
Tamm S, Tse KYK, Hellier J, Saunders KEA, Harmer CJ, Espie CA, Reid M, Kyle SD.
JAMA network open · 2025-02-03
DOI: 10.1001/jamanetworkopen.2024.61502 ↗PubMed · 40014347 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Exercise improved sleep-quality scores in adults 45 and older with sleep disorders
Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.
Journal of Exercise Science & Fitness
Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults
Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.
Sleep
Sleep extension cut daily energy intake by about 270 kcal in adults with overweight
In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.
JAMA Internal Medicine
Six hours or less of sleep at 50 and 60 linked to higher dementia risk
In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.
Nature Communications

